ESMO Clinical Practice Guidelines: CNS Malignancies

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

The ESMO Clinical Practice Guidelines on Central Nervous System Malignancies currently focus on high-grade malignant glioma (newly diagnosed patients, glioblastoma (WHO grade IV) and anaplastic astrocytoma, oligoastrocytoma and oligodendroglioma (WHO grade III)) and include information on: incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.